Clinical Trial

Meibomian Gland Changes in Ocular Prosthesis Users

Study acronym: MGPRO
Completed
View on ClinicalTrials.gov →
Summary
This observational cross-sectional study aims to evaluate meibomian gland loss and dry eye symptoms in patients using unilateral ocular prostheses. The study compares the prosthetic eye with the contralateral healthy eye using the DEQ-5 questionnaire and meibography obtained with the Oculus Keratograph 5M. Additional ocular surface parameters, including conjunctival hyperemia and tear meniscus height, are also evaluated. The objective is to determine whether ocular prosthesis wear is associated with morphological changes in the meibomian glands and increased dry eye symptoms.
Trial Details
NCT Number NCT07621952
Lead Sponsor Instituto de Oftalmología Fundación Conde de Valenciana
Conditions Dry Eye, Meibomian Gland Dysfunction (Disorder), Anophthalmic Socket Syndrome, Ocular Prostheses
Enrollment 20 participants
Start Date 2023-08-18
Primary Completion 2024-07-25 (estimated)
Study Completion 2024-07-26 (estimated)
Updated on ClinicalTrials.gov 2026-06-02